FeesSafety
Pluang+

Federal Realty Investment Trust gets buy rating after third straight earnings beat and strong leasing growth.

Company Fundamentals
03 Nov 2026, 14:10 WIB
Seeking Alpha
View Source
Bullish
Federal Realty Investment Trust gets buy rating after third straight earnings beat and strong leasing growth.

Federal Realty Investment Trust (FRT) reported its third consecutive earnings beat in Q3, driven by 14% rent growth from new leases and the acquisition of a key retail center in Birmingham. Despite some technical bearish signals and higher debt levels, FRT maintains strong fundamentals with a 93.8% occupancy rate, investment-grade credit ratings, and consistent growth in funds from operations per share. The REIT's premium valuation is supported by resilient margins and a safe dividend, justifying a buy rating, although future upside may be more limited.

Federal Realty Investment Trust's Q3 results provide context for real estate market activity. For readers following real estate stocks, here is Pluang's market snapshot as of Nov 03, 2026 18:41 WIB: Out of 47 priced US real estate stocks, 20 rose and 24 fell today. Prologis Inc (PLD) traded at USD 128.35 with 85% buy orders, while Alexandria Real Estate Equities Inc (ARE) was at USD 42.15 with 78% sell orders.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
29 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
29 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
29 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App